PUBLIZIERTER Beitrag für wissenschaftliche Veranstaltung
The Human Anti-HIV Antibodies 2F5, PG9 and 2G12 Differ in Their Proteolytic Susceptibility
Niemer M, Mehofer U, Torres Acosta J, Verdianz M, Henkel T, Loos A, et al. The Human Anti-HIV Antibodies 2F5, PG9 and 2G12 Differ in Their Proteolytic Susceptibility. In: Khassidov A, Glaser W, Klimek C , editors. 6th ÖGMBT Annual Meeting "Life Sciences Meet Entrepreneurship". 2014.
Externe Links und Eigenschaften der Publikation:
BOKU Autor*innen
Herta Steinkellner
Ao.Univ.-Prof.i.R. Mag.rer.nat.Dr.nat.techn. Herta Steinkellner
Lukas Mach
Univ.Prof. Dipl.-Ing.Dr.nat.techn. Lukas Mach
Richard Strasser
Assoc. Prof. Dr. Richard Strasser
Andreas Loos
Dipl.-Ing.Dr. Andreas Loos
Juan Antonio Torres Acosta
Dr. Juan Antonio Torres Acosta
Melanie Paireder
Mag. Melanie Paireder
Maria Verdianz
Maria Verdianz
Daniel Maresch
Daniel Maresch B.Sc.
Ulrich Mehofer
Dipl.-Ing. Ulrich Mehofer
Theresa Henkel
Theresa Henkel